Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A mutant, PN6017, of the cellular slime mold Polysphondylium pallidum was selected by cell-surface labeling with a monoclonal antibody, mAb 293, and fluorescence-activated cell sorting. The antibody was directed against an L-fucose-containing epitope on glycoproteins, designated ep 293, and the mutant showed reduced and delayed expression of this epitope. PN6017 was distinguished from other mutants of this kind by extensive microcyst formation on agar plates under conditions where the wild type formed only sparse microcysts. In suspension cultures transformation of cells into microcysts was negligible in the wild type, and close to 100% in the mutant. Under these conditions microcyst formation in the mutant began at 5-7 h of
starvation
. At the same time expression of ep 293 and also of a developmentally regulated cytoplasmic protein,
pallidin
, became detectable. This coincidence in time suggests that microcyst formation in PN6017 is coupled to the same control mechanism as the two other developmentally regulated processes.
...
PMID:A microcyst-overproducing mutant of Polysphondylium pallidum. 242 Apr 73
Binding of a monoclonal antibody, mAb293, to cell-surface glycoproteins of Polysphondylium pallidum is known to be blocked by L-fucose, and Fab of this antibody has been shown to inhibit intercellular adhesion of aggregation-competent cells. Mutants with delayed expression of the carbohydrate epitope, ep293, recognized by the antibody, have been shown to be retarded and altered in cell aggregation. The present study shows that ep293 is a modification of carbohydrate structure that is subject to regulation not only in mutant but also in wild-type cells; ep293 is expressed at an early stage of exponential growth in wild-type and only after 12 h of
starvation
in mutant PN6002. Proteins are already glycosylated before the epitope is expressed. The developmental regulation of
pallidin
, a lectin known to be an unglycosylated protein, was investigated in parallel with ep293 using a monoclonal antibody. Pallidin was expressed at about the same time as the carbohydrate epitope in cells of the wild-type as well as the mutant. These results indicate a regulatory signal to which various events are coupled. Induction of ep293 and expression of
pallidin
are two of these events, and mutants such as PN6002 are altered in the timing of the signal.
...
PMID:Mutants of Polysphondylium pallidum showing delayed modifications of glycoproteins are altered in a regulatory signal for development. 244 7